Skip to main navigation Skip to search Skip to main content

The antiplasmodial activity of norcantharidin analogs

  • Joanna Bajsa
  • , Adam McCluskey
  • , Christopher P. Gordon
  • , Scott G. Stewart
  • , Timothy A. Hill
  • , Rajnish Sahu
  • , Stephen O. Duke
  • , Babu L. Tekwani

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

The antiplasmodial activities of sixty norcantharidin analogs were tested in vitro against a chloroquine sensitive (D6, Sierra Leone) and chloroquine resistant (W2) strains of Plasmodium falciparum. Forty analogs returned IC50 values <500 μM against at least one of the P. falciparum strains examined. The ring open compound 24 ((1S,4R)-3-(allylcarbamoyl)-7- oxabicyclo[2.2.1]heptane-2-carboxylic acid) is the most active aliphatic analog (D6 IC50 = 3.0 ± 0.0 and W2 IC50 = 3.0 ± 0.8 μM) with a 20-fold enhancement relative to norcantharidin. Surprisingly, seven norcantharimides also displayed good antiplasmodial activity with the most potent, 5 returning D6 = 8.9 ± 0.9 and W2 IC50 = 12.5 ± 2.2 μM, representing a fivefold enhancement over norcantharidin.
Original languageEnglish
Pages (from-to)6688-6695
Number of pages8
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number22
DOIs
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The antiplasmodial activity of norcantharidin analogs'. Together they form a unique fingerprint.

Cite this